Skip to main content
DBD logo
DBD
(NYSE)
Diebold Nixdorf, Incorporated
$82.69-- (--)
Loading... - Market loading

Diebold Nixdorf, Incorporated (DBD) Stock Price & Financial Analysis

Diebold Nixdorf, Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$81.05 - $83.47
52-Week High$89.05
52-Week Low$51.46
Open$81.44
Volume218.28K
Average Volume (3M)282.04K
Market Cap2.99B
Shares Outstanding35.70M
P/E Ratio (TTM)27.73
Price to Sales (P/S)0.78
Price to Book (P/B)2.92
EV/EBITDA11.41
Revenue (TTM)3.86B
Net Income (TTM)107.90M
Free Cash Flow (TTM)274.60M
EPS (TTM)$2.95
Profit Margin2.80%
Operating Margin6.47%
Return on Equity (ROE)10.51%
Debt to Equity0.97
50-Day MA$80.16
200-Day MA$70.29
52-Week Change61.76%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateFeb 23, 2018

Frequently Asked Questions About Diebold Nixdorf, Incorporated

What is the current stock price for DBD?

As of the latest trading session, DBD stock trades at $82.69. The 52-week range is $51.46–$89.05, with a day range of $81.05–$83.47.

What is the P/E ratio for DBD?

Diebold Nixdorf, Incorporated's trailing P/E ratio is 27.7, meaning investors pay $27.7 for every $1 of annual earnings. Diebold Nixdorf, Incorporated operates in the Technology sector.

Does DBD pay dividends?

Diebold Nixdorf, Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DBD?

Based on 1 analyst, the consensus for DBD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DBD?

Diebold Nixdorf, Incorporated's market capitalization is $2.95B, classifying it as a mid-cap company. Diebold Nixdorf, Incorporated operates in the Technology sector within the Software - Application industry.